PULMONX CORPORATION — Income Charts
2 years of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$90M
Cost of Revenue
$23M
Gross Profit
$67M
R&D
$19M
SG&A
$101M
D&A
$1M
Operating Income
$-54M
EBITDA
$-53M
Interest Expense
$3M
Interest Income
$3M
Other Income/Expense
$790K
Pretax Income
$-53M
Tax Provision
$626K
Net Income
$-54M
Gross Margin
74.2%
Operating Margin
-59.3%
Net Margin
-59.7%
Effective Tax Rate
-1.2%
Deferred Tax Assets
$5M
Deferred Tax Liabilities
$69K
DTA Valuation Allowance
$100M
Tax Credit Carryforwards
$8M
NOL Carryforwards
$77M
ETR (Continuing Operations)
-1.2%
ETR Federal Statutory
21.0%
ETR State + Local (pp)
-0.1%
ETR Foreign Differential (pp)
0.4%
Operating Lease Cost
$3M
Revenue YoY Variation
8.0%
Income YoY Variation
7.0%